News

ABM Industries reported Q1 CY2026 revenue of $2.29 billion, an 8.4 % year‑over‑year increase that exceeded analyst estimates by 3.1 %. Adjusted earnings per share were $0.90, 2.4 % above consensus, yet still fell short of the $0.92 estimate, marking the fourth consecutive quarter of EPS misses. Operating margin stayed at 3.8 %, while the adjusted m...

Full article

Guardian Pharmacy's strong earnings surprise record is a key driver of its outperformance, having beaten the Zacks Consensus Estimate in each of the last four quarters. The company is expected to post earnings of $1.26 per share on $1.41 in revenues for the current fiscal year, and $1.37 per share on $1.53 in revenues for the next fiscal year.

Full article

Shares of Guardian Pharmacy Services (GRDN) have been rising, with the stock up 12.2% over the past month and hitting a new 52‑week high of $41.79 in the previous session. The company has gained 34.5% since the start of the year compared to the -4.4% move for the Zacks Medical sector and the -9.3% return for the Zacks Medical‑Drugs industry.

Full article

The stock price is trading 2.6% below the analyst target of €42.84 and 24.6% below Simply Wall St's estimate of fair value. The recent short-term momentum shows a slight increase in share price over the last 30 days. As part of its "RC Forward" plan, Rémy Cointreau will review its portfolio to determine which brands still fit long-term priorities a...

Full article

The plan puts ENXTPA:RCO in the middle of ongoing consolidation in spirits, influencing how peers respond. Investors will focus on execution milestones and any announced transactions over the coming periods. The company's current P/E ratio is below the sector average, indicating potential undervaluation. However, profit margins are lower than last...

Full article

Rémy Cointreau's "RC Forward" transformation plan aims to reevaluate its entire drinks portfolio for possible disposals and acquisitions, signaling renewed M&A ambitions at a time of sector consolidation in spirits. This strategic review could lead to asset sales, brand swaps or targeted acquisitions, depending on management's assessment of growth...

Full article

The fair value estimate for Weir Group (WEIR.L) has been revised downward to £32.46 per share from £33.55. This adjustment reflects analysts' reevaluation of growth expectations and execution risks, with net profit margin remaining largely unchanged at 13.08%. Analysts have also made adjustments to their price targets, with Citi retaining a Buy rat...

Full article

Another valuation approach, Price vs Earnings (P/E), shows that Ackermans & Van Haaren's P/E ratio of 14.8x is slightly above the peer average and industry average. However, Simply Wall St's Fair Ratio, which takes into account various factors such as earnings growth and risk profile, suggests that the shares are undervalued on this metric.

Full article

A Discounted Cash Flow (DCF) analysis by Simply Wall St suggests that Ackermans & Van Haaren is undervalued, with an estimated intrinsic value of €418.97 per share compared to the current price of €267.8. This represents a 36.1% discount, indicating that the stock may be trading below its fair value.

Full article

Ackermans & Van Haaren's stock performance has been mixed, with a 1.5% drop over the past week and 9.6% decline over the past month. However, year-to-date returns stand at 15.1%, while the stock has gained 19.6% over the past year. The company's long-term returns of 80.4% over three years and 112.5% over five years have been highlighted in recent c...

Full article